IL95918A0 - Fibrinogen receptor antagonists and pharmaceutical compositions containing them - Google Patents

Fibrinogen receptor antagonists and pharmaceutical compositions containing them

Info

Publication number
IL95918A0
IL95918A0 IL95918A IL9591890A IL95918A0 IL 95918 A0 IL95918 A0 IL 95918A0 IL 95918 A IL95918 A IL 95918A IL 9591890 A IL9591890 A IL 9591890A IL 95918 A0 IL95918 A0 IL 95918A0
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
fibrinogen receptor
compositions containing
receptor antagonists
fibrinogen
Prior art date
Application number
IL95918A
Other languages
English (en)
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of IL95918A0 publication Critical patent/IL95918A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/75—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL95918A 1989-10-13 1990-10-08 Fibrinogen receptor antagonists and pharmaceutical compositions containing them IL95918A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US42104989A 1989-10-13 1989-10-13

Publications (1)

Publication Number Publication Date
IL95918A0 true IL95918A0 (en) 1991-07-18

Family

ID=23668978

Family Applications (1)

Application Number Title Priority Date Filing Date
IL95918A IL95918A0 (en) 1989-10-13 1990-10-08 Fibrinogen receptor antagonists and pharmaceutical compositions containing them

Country Status (17)

Country Link
US (1) US5374622A (fr)
EP (1) EP0422937B1 (fr)
JP (1) JP2559289B2 (fr)
KR (1) KR910007958A (fr)
AT (1) ATE102219T1 (fr)
AU (1) AU644380B2 (fr)
CA (1) CA2027314A1 (fr)
DE (1) DE69007004T2 (fr)
DK (1) DK0422937T3 (fr)
ES (1) ES2062400T3 (fr)
FI (1) FI905023A0 (fr)
IE (1) IE66253B1 (fr)
IL (1) IL95918A0 (fr)
NO (1) NO904430L (fr)
NZ (1) NZ235564A (fr)
PT (1) PT95581A (fr)
ZA (1) ZA908159B (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5686568A (en) * 1989-06-16 1997-11-11 Cor Therapeutics, Inc. Platelet aggregration inhibitors
US5795867A (en) * 1989-06-16 1998-08-18 Cor Therapeutics, Inc. Platelet aggregation inhibitors
US5643872A (en) * 1989-10-23 1997-07-01 Smithkline Beecham Corporation Cyclic anti-aggregatory peptides
US5645815A (en) 1991-02-08 1997-07-08 Diatide, Inc. Radiolabled compounds for thrombus imaging
US5736122A (en) * 1991-02-08 1998-04-07 Diatide, Inc. Technetium-99m labeled peptides for thrombus imaging
DE69230525T2 (de) * 1991-02-08 2000-06-21 Diatide, Inc. Technetium-99m markierte Polypeptide zur Bildformung
US6019958A (en) * 1991-02-08 2000-02-01 Diatide, Inc. Technetium-99m labeled peptides for imaging inflammation
US6107459A (en) * 1991-02-08 2000-08-22 Diatide, Inc. Technetium-99m labeled peptides for diagnostic imaging
US5830856A (en) * 1991-02-08 1998-11-03 Diatide, Inc. Radiolabeled compounds for thrombus imaging
US5561220A (en) * 1991-02-08 1996-10-01 Diatech, Inc. Technetium-99m labeled peptides for imaging inflammation
IL103252A (en) 1991-09-30 1997-03-18 Du Pont Merck Pharma CYCLIC COMPOUNDS USEFUL AS INHIBITORS OF PLATELET GLYCOPROTEIN IIb/IIIa AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
US5635477A (en) * 1991-09-30 1997-06-03 The Dupont Merck Pharmaceutical Company Cyclic compounds useful as inhibitors of platelet glycoprotein IIB/IIIA
US5565449A (en) * 1991-10-18 1996-10-15 Genentech, Inc. Nonpeptidyl integrin inhibitors having specificity for the GPIIb IIIa receptor
US5250679A (en) * 1991-10-18 1993-10-05 Genentech, Inc. Nonpeptidyl platelet aggregation inhibitors having specificity for the GPIIb III.sub. receptor
DE69229004D1 (de) * 1991-11-07 1999-05-27 Univ Southern California Zusammensetzungen und verfahren zur verhinderung der adhäsionbildung
US5968476A (en) * 1992-05-21 1999-10-19 Diatide, Inc. Technetium-99m labeled peptides for thrombus imaging
US5338725A (en) * 1992-06-30 1994-08-16 The Research Foundation Of The State University Of New York Anti-aggregatory agents for platelets
DE69332203T2 (de) * 1992-10-02 2003-05-28 Diatide, Inc. Multimerische mehrzweckwirkstoffe gegen thrombose
AU5594294A (en) * 1992-11-18 1994-06-08 Du Pont Merck Pharmaceutical Company, The Cyclic compounds linked by a heterocyclic ring useful as inhibitors of platelet glycoprotein iib/iiia
CA2159072A1 (fr) * 1993-03-29 1994-10-13 Lin-Hua Zhang Nouveaux procedes et composes intermediaires utilises pour la preparation d'inhibiteurs iib/iiia de glycoproteines de plaquettes
DK0693941T3 (da) * 1993-04-08 2002-10-14 Diatide Inc Radiomærkede forbindelser til trombe-billeddannelse
US5646000A (en) * 1994-09-29 1997-07-08 Merck & Co., Inc. Compounds and methods for identifying activated platelets
US5858972A (en) * 1996-01-11 1999-01-12 La Jolla Cancer Research Foundation Antithrombotic agents and methods of use
US6623981B2 (en) * 1998-01-27 2003-09-23 Bristol-Myers Squibb Company Detection of patients at risk for developing integrin antagonist/agonist mediated disease states
AU736951C (en) 1998-03-19 2003-02-20 Bristol-Myers Squibb Company Biphasic controlled release delivery system for high solubility pharmaceuticals and method
AU3563799A (en) 1998-04-16 1999-11-01 Texas Biotechnology Corporation Compounds that inhibit the binding of integrins to their receptors
US6808698B1 (en) 1999-03-26 2004-10-26 Bristol-Myers Squibb Pharma Company Method for localization of blood clots
US6685914B1 (en) 1999-09-13 2004-02-03 Bristol-Myers Squibb Pharma Company Macrocyclic chelants for metallopharmaceuticals
US7317104B2 (en) 2003-06-13 2008-01-08 Bristol-Myers Squibb Pharma Company Chelants and macrocyclic metal complex radiopharmaceuticals thereof
US7319149B2 (en) 2003-06-13 2008-01-15 Bristol-Myers Squibb Pharma Company Chelants and macrocyclic metal complex radiopharmaceuticals thereof
JP6042330B2 (ja) 2010-07-09 2016-12-14 ビーエイチヴィ ファーマ、インコーポレイテッド レモグリフロジンを含めた半減期が短い医薬品のための組合せ即時／遅延放出送達システム

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5921656A (ja) * 1982-07-28 1984-02-03 Takeda Chem Ind Ltd ポリペプチド誘導体
GB8305985D0 (en) * 1983-03-04 1983-04-07 Szelke M Enzyme inhibition
US4988621A (en) * 1985-05-24 1991-01-29 La Jolla Cancer Research Foundation Peptides in cell detachment and aggregation
ES2052595T3 (es) * 1986-12-15 1994-07-16 Inst Nat Sante Rech Med Nuevos derivados peptidicos y su aplicacion en especial en terapeutica.
US4857508A (en) * 1987-12-03 1989-08-15 Monsanto Company Novel platelet-aggregation inhibitor peptide derivatives
JP2547263B2 (ja) * 1987-12-10 1996-10-23 ラ・ジョラ・キャンサー・リサーチ・ファウンデーション 立体配座的に安定化された細胞付着ペプチド
ZW6189A1 (en) * 1988-05-09 1990-05-09 Smithkline Beckman Corp Anti-aggregatory peptides
JP2945680B2 (ja) * 1988-09-09 1999-09-06 旭硝子株式会社 ペプチド誘導体およびその用途
CA2008116C (fr) * 1989-02-23 2001-11-20 Thomas Weller Derives de glycine
US4952562A (en) * 1989-09-29 1990-08-28 Rorer Pharmaceutical Corporation Anti-thrombotic peptides and pseudopeptides
NZ235563A (en) * 1989-10-13 1993-04-28 Merck & Co Inc Fibrinogen receptor antagonist and pharmaceutical composition
AU6470590A (en) * 1989-10-23 1991-04-26 Smithkline Beecham Corporation Cyclic anti-aggregatory peptides

Also Published As

Publication number Publication date
IE903629A1 (en) 1991-04-24
FI905023A0 (fi) 1990-10-12
NO904430L (no) 1991-04-15
JP2559289B2 (ja) 1996-12-04
DE69007004T2 (de) 1994-10-06
KR910007958A (ko) 1991-05-30
EP0422937A1 (fr) 1991-04-17
DE69007004D1 (de) 1994-04-07
ATE102219T1 (de) 1994-03-15
AU6456890A (en) 1991-04-18
EP0422937B1 (fr) 1994-03-02
US5374622A (en) 1994-12-20
NZ235564A (en) 1993-10-26
AU644380B2 (en) 1993-12-09
NO904430D0 (no) 1990-10-12
PT95581A (pt) 1991-09-13
DK0422937T3 (da) 1994-03-28
IE66253B1 (en) 1995-12-27
CA2027314A1 (fr) 1991-04-14
ZA908159B (en) 1991-07-31
ES2062400T3 (es) 1994-12-16
JPH03206097A (ja) 1991-09-09

Similar Documents

Publication Publication Date Title
IL95918A0 (en) Fibrinogen receptor antagonists and pharmaceutical compositions containing them
IL95917A0 (en) Fibrinogen receptor antagonists and pharmaceutical compositions containing them
DK0380063T3 (da) 1,2-Cyclohexylaminoarylamider til anvendelse som analgetika
ATE155486T1 (de) Zyklische peptide und ihre verwendung
ZM1290A1 (en) N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran,dihyn-(3-hydroxy-4-piperidinyl(dihydrobenzofuran,dihyddro-2h-benzopyran or dihydrobenzodioxin)carboxamidro-2h-benzopyran or dihydrobenzodioxin)carboxamide derivatives e derivatives
EP0231081A3 (en) Hydroxamic acids
NZ215700A (en) Substituted n-((4-piperidinyl)alkyl) bicyclic condensed oxazol- and thiazolamines and pharmaceutical compositions
IT1228288B (it) Composti ad attivita' antiserotoninica
TW207950B (fr)
EP0325343A3 (en) L-glutamic acid derivatives
ES2104688T3 (es) Un procedimiento para la preparacion de un compuesto de tio-3-cefem 3-sustituido.
IL95619A0 (en) N-azabicyclo(3.3.0)octane amides of aromatic acids and pharmaceutical compositions containing them
ATE46347T1 (de) Immunostimulierende peptide.
DE69011702D1 (de) Derivate von Aminocarboxylsäure.